BIOMAT Database Logo BIOMAT Database Logo

[Effectiveness of cytostatic therapy of polycythemia vera]. 1986

L G Kovaleva, and P I Kho

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008927 Mitobronitol Brominated analog of MANNITOL which is an antineoplastic agent appearing to act as an alkylating agent. Dibromomannitol,Myelobromol,NSC-94,100,NSC-94100,NSC 94,100,NSC 94100,NSC94,100,NSC94100
D010761 Phosphorus Radioisotopes Unstable isotopes of phosphorus that decay or disintegrate emitting radiation. P atoms with atomic weights 28-34 except 31 are radioactive phosphorus isotopes. Radioisotopes, Phosphorus
D011087 Polycythemia Vera A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs. Erythremia,Osler-Vaquez Disease,Polycythemia Rubra Vera,Polycythemia Ruba Vera,Primary Polycythemia,Disease, Osler-Vaquez,Erythremias,Osler Vaquez Disease,Polycythemia Ruba Veras,Polycythemia Rubra Veras,Polycythemia, Primary,Polycythemias, Primary,Primary Polycythemias,Ruba Vera, Polycythemia,Ruba Veras, Polycythemia,Vera, Polycythemia Ruba,Vera, Polycythemia Rubra,Veras, Polycythemia Ruba,Veras, Polycythemia Rubra
D002066 Busulfan An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. Busulphan,Busulfan Wellcome,Busulfex,Glyzophrol,Myelosan,Mylecytan,Myleran,Myléran,n-Butane-1,3-di(methylsulfonate),Wellcome, Busulfan
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001388 Aziridines Saturated azacyclopropane compounds. They include compounds with substitutions on CARBON or NITROGEN atoms. Ethyleneimines,Azacyclopropanes, Saturated,Dimethyleneimines,Saturated Azacyclopropanes

Related Publications

L G Kovaleva, and P I Kho
[Cytostatic therapy of chronic myelosis and polycythemia vera with myelobromol (dibrommannitol)].
January 1969, Folia haematologica (Leipzig, Germany : 1928),
L G Kovaleva, and P I Kho
[Cytostatic treatment of polycythemia vera with a methylbenzylhydrazine derivative].
January 1966, Deutsche medizinische Wochenschrift (1946),
L G Kovaleva, and P I Kho
[Therapy of polycythemia vera].
February 1960, La Clinica terapeutica,
L G Kovaleva, and P I Kho
[Therapy of polycythemia vera].
October 1960, Schweizerische medizinische Wochenschrift,
L G Kovaleva, and P I Kho
[Therapy of polycythemia vera].
October 1969, Minerva medica,
L G Kovaleva, and P I Kho
[The therapy of polycythemia vera].
October 1967, Deutsche medizinische Wochenschrift (1946),
L G Kovaleva, and P I Kho
Pipobroman therapy of polycythemia vera.
May 1982, Blood,
L G Kovaleva, and P I Kho
Melphalan therapy of polycythemia vera.
July 1970, Blood,
L G Kovaleva, and P I Kho
[Radiophosphorus therapy of polycythemia vera].
November 1973, Therapeutische Umschau. Revue therapeutique,
L G Kovaleva, and P I Kho
[P32 therapy of polycythemia vera].
May 1963, Arztliche Forschung,
Copied contents to your clipboard!